During the past decade, Ospedale del Mare conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale del Mare" #1 sponsor was "Fadoi Foundation, Italy" with 2 trials, followed by "Ascelia Pharma AB" with 1 trials sponsored, "BioNTech SE" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Federico II University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale del Mare" #1 collaborator was "AdvicePharma Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale del Mare" are "Acute Coronary Syndrome" (1 trials), "All Tumor Types" (1 trials), "Chronic Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials) and "Hospitalization" (1 trials). Many other conditions were trialed in "Ospedale del Mare" in a lesser frequency.

Most popular intervention types in "Ospedale del Mare" are "Drug" (2 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "BNT113" (1 trials), "Mangoral" (1 trials), "Pembrolizumab" (1 trials), "Percutaneous coronary intervention with implantation of amphilimus-eluting stents for coronary artery disease." (1 trials) and "Percutaneous coronary intervention with implantation of everolimus-eluting stents for coronary artery disease." (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale del Mare" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale del Mare". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ospedale del Mare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale del Mare, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".